# Immunovant, Inc.: filings

IMVT · Nasdaq · CIK 1764013 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/imvt.md) · [Financials](/companies/imvt/financials.md) · [Filings](/companies/imvt/filings.md) · [Insiders](/companies/imvt/insiders.md)

## Reports and events: 143 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 324, 8-K 84, 3 34, 144 26, 10-Q 23, DEFA14A 16, CORRESP 13, UPLOAD 12, SC 13G/A 11, S-8 8, 10-K 7, 424B3 7, DEF 14A 7, SC 13D/A 7, SC 13G 6, 424B5 5, EFFECT 5, S-1/A 5, S-1 4, 424B4 3, ARS 3, DRS 3, FWP 3, SCHEDULE 13D/A 3, SCHEDULE 13G/A 3, POS EX 2, PRER14A 2, S-1MEF 2, SC 13D 2, SEC STAFF LETTER 2, 25-NSE 1, 424B7 1, 4/A 1, 8-A12B 1, 8-K/A 1, CERT 1, D 1, DEFM14A 1, DEFR14A 1, DRS/A 1, DRSLTR 1, PRE 14A 1, PREM14A 1, S-3 1, S-3ASR 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-03 | 17:05 ET | [8-K](/filings/0001764013-26-000106.md) | 5.07 Shareholder vote results | 0001764013-26-000106 |
| 2026-08-06 | 07:29 ET | [10-Q](/filings/0001764013-26-000101.md) | Quarterly report, period 2026-06-30 | 0001764013-26-000101 |
| 2026-08-06 | 07:15 ET | [8-K](/filings/0001764013-26-000100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-26-000100 |
| 2026-07-22 | 16:10 ET | [DEF 14A](/filings/0001764013-26-000092.md) | Proxy statement, period 2026-09-02 | 0001764013-26-000092 |
| 2026-05-20 | 07:28 ET | [10-K](/filings/0001764013-26-000064.md) | Annual report, period 2026-03-31 | 0001764013-26-000064 |
| 2026-05-20 | 07:14 ET | [8-K](/filings/0001764013-26-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-26-000062 |
| 2026-02-06 | 07:24 ET | [10-Q](/filings/0001764013-26-000011.md) | Quarterly report, period 2025-12-31 | 0001764013-26-000011 |
| 2026-02-06 | 07:16 ET | [8-K](/filings/0001764013-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-26-000010 |
| 2025-12-12 | 17:20 ET | [SCHEDULE 13D/A](/filings/0001140361-25-045411.md) | Ownership report, active investor, amended | 0001140361-25-045411 |
| 2025-12-12 | 16:15 ET | [8-K](/filings/0001193125-25-317577.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-317577 |
| 2025-12-11 | 06:39 ET | [8-K](/filings/0001193125-25-314994.md) | 8.01 Other events | 0001193125-25-314994 |
| 2025-11-21 | 08:00 ET | [8-K](/filings/0001764013-25-000153.md) | 5.02 Departure or appointment of officers or directors | 0001764013-25-000153 |
| 2025-11-10 | 07:30 ET | [10-Q](/filings/0001764013-25-000149.md) | Quarterly report, period 2025-09-30 | 0001764013-25-000149 |
| 2025-11-10 | 07:15 ET | [8-K](/filings/0001764013-25-000148.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000148 |
| 2025-09-03 | 13:09 ET | [8-K](/filings/0001764013-25-000136.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-25-000136 |
| 2025-08-28 | 16:13 ET | [8-K](/filings/0001764013-25-000132.md) | 5.07 Shareholder vote results | 0001764013-25-000132 |
| 2025-08-11 | 07:29 ET | [10-Q](/filings/0001764013-25-000129.md) | Quarterly report, period 2025-06-30 | 0001764013-25-000129 |
| 2025-08-11 | 07:14 ET | [8-K](/filings/0001764013-25-000128.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000128 |
| 2025-07-29 | 16:57 ET | [8-K](/filings/0001764013-25-000121.md) | 5.02 Departure or appointment of officers or directors | 0001764013-25-000121 |
| 2025-07-09 | 16:54 ET | [DEF 14A](/filings/0001764013-25-000103.md) | Proxy statement, period 2025-08-27 | 0001764013-25-000103 |
| 2025-05-29 | 07:30 ET | [10-K](/filings/0001764013-25-000092.md) | Annual report, period 2025-03-31 | 0001764013-25-000092 |
| 2025-05-29 | 07:14 ET | [8-K](/filings/0001764013-25-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000091 |
| 2025-04-21 | 07:54 ET | [SCHEDULE 13D/A](/filings/0001140361-25-014645.md) | Ownership report, active investor, amended | 0001140361-25-014645 |
| 2025-04-21 | 07:18 ET | [8-K](/filings/0001764013-25-000078.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-25-000078 |
| 2025-03-19 | 07:51 ET | [8-K](/filings/0001764013-25-000037.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-25-000037 |
| 2025-02-06 | 06:45 ET | [10-Q](/filings/0001764013-25-000026.md) | Quarterly report, period 2024-12-31 | 0001764013-25-000026 |
| 2025-02-06 | 06:37 ET | [8-K](/filings/0001764013-25-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000024 |
| 2025-01-24 | 17:24 ET | [8-K](/filings/0001193125-25-012329.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-012329 |
| 2025-01-15 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001140361-25-001185.md) | Ownership report, active investor, amended | 0001140361-25-001185 |
| 2025-01-14 | 08:09 ET | [8-K](/filings/0001764013-25-000009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-25-000009 |
| 2025-01-13 | 08:07 ET | [8-K](/filings/0001764013-25-000007.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-25-000007 |
| 2024-11-07 | 06:49 ET | [10-Q](/filings/0001764013-24-000184.md) | Quarterly report, period 2024-09-30 | 0001764013-24-000184 |
| 2024-11-07 | 06:42 ET | [8-K](/filings/0001764013-24-000183.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-24-000183 |
| 2024-09-09 | 07:40 ET | [8-K](/filings/0001764013-24-000162.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-24-000162 |
| 2024-08-13 | 16:12 ET | [8-K](/filings/0001764013-24-000150.md) | 5.07 Shareholder vote results | 0001764013-24-000150 |
| 2024-08-06 | 16:19 ET | [10-Q](/filings/0001764013-24-000148.md) | Quarterly report, period 2024-06-30 | 0001764013-24-000148 |
| 2024-08-06 | 16:13 ET | [8-K](/filings/0001764013-24-000147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-24-000147 |
| 2024-06-26 | 06:56 ET | [DEF 14A](/filings/0001764013-24-000114.md) | Proxy statement, period 2024-08-12 | 0001764013-24-000114 |
| 2024-05-29 | 16:36 ET | [10-K](/filings/0001764013-24-000109.md) | Annual report, period 2024-03-31 | 0001764013-24-000109 |
| 2024-05-29 | 16:17 ET | [8-K](/filings/0001764013-24-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-24-000107 |
| 2024-02-12 | 07:05 ET | [10-Q](/filings/0001764013-24-000026.md) | Quarterly report, period 2023-12-31 | 0001764013-24-000026 |
| 2024-02-12 | 07:02 ET | [8-K](/filings/0001764013-24-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-24-000025 |
| 2024-01-09 | 08:08 ET | [8-K](/filings/0001764013-24-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-24-000003 |
| 2023-12-20 | 16:37 ET | [8-K](/filings/0001764013-23-000159.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000159 |
| 2023-11-28 | 07:43 ET | [8-K](/filings/0001764013-23-000150.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000150 |
| 2023-11-09 | 07:13 ET | [10-Q](/filings/0001764013-23-000133.md) | Quarterly report, period 2023-09-30 | 0001764013-23-000133 |
| 2023-11-09 | 07:06 ET | [8-K](/filings/0001764013-23-000131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-23-000131 |
| 2023-10-04 | 17:19 ET | [SC 13D/A](/filings/0001140361-23-046991.md) | Ownership report, active investor, amended | 0001140361-23-046991 |
| 2023-09-28 | 17:23 ET | [8-K](/filings/0001193125-23-245815.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-245815 |
| 2023-09-26 | 07:45 ET | [8-K](/filings/0001764013-23-000114.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000114 |

Page 1 of 3. [Older](/companies/imvt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:48 ET. No prices; not investment advice.